Performance Evaluations of the Abbott Alinity m Assay in Comparison with the Abbott m2000 Assay for Hepatitis B and Hepatitis C Viruses-Reference-Cited by-同舟云学术

Performance Evaluations of the Abbott Alinity m Assay in Comparison with the Abbott m2000 Assay for Hepatitis B and Hepatitis C Viruses

Published:2020-09-30 Issue:3 Volume:42 Page:150-155
ISSN:2384-2458
Container-title:Laboratory Medicine and Quality Assurance
language:en
Short-container-title:Lab Med Qual Assur

Author:

Yoo Jaeeun¹²,Son Beom Se¹,Han Eunhee¹²,Yu Gyong Gi¹,Lee Seungok¹²

Affiliation:

1. Department of Laboratory Medicine, Incheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Incheon, Korea

2. Department of Laboratory Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea

Funder

Dow Biomedica Inc.

Publisher

Korean Association of Quality Assurance for Clinical Laboratory

Link

http://pdf.medrang.co.kr/LMQA/2020/042/LMQA042-03-06.pdf

Reference11 articles.

1. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013

2. 2019 Chinese clinical guidelines for the management of hepatocellular carcinoma: updates and insights

3. Tholen DW, Kallner A, Kennedy JW, Krouwer JS, Meier K. Evaluation of precision performance of quantitative measurement methods; approved guideline: EP5-A2. 2nd ed. Wayne (PA): Clinical and Laboratory Standards Institute, 2004.

4. Tholen DW, Kroll M, Astles JR, Caffo AL, Happe TM, Krouwer J, et al. Evaluation of the linearity of quantitative measurement procedures: a statistical approach; approved guideline. Wayne (PA): Clinical and Laboratory Standards Institute, 2003.

5. Pierson-Perry JF, Vaks JE, Durham AP, Fischer C, Gutenbrunner C, Hillyard D, et al. Evaluation of detection capability for clinical laboratory measurement procedures; approved guideline. 2nd ed. Wayne (PA): Clinical and Laboratory Standards Institute, 2012.